Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A phase I clinical trial of recombinant interleukin 2 following high dose chemo-radiotherapy for haematological malignancy: applicability to the elimination of minimal residual disease.
Gottlieb DJ, Brenner MK, Heslop HE, Bianchi AC, Bello-Fernandez C, Mehta AB, Newland AC, Galazka AR, Scott EM, Hoffbrand AV, et al. Gottlieb DJ, et al. Among authors: galazka ar. Br J Cancer. 1989 Oct;60(4):610-5. doi: 10.1038/bjc.1989.324. Br J Cancer. 1989. PMID: 2803933 Free PMC article.
Differences between in vivo and in vitro activation of cancer patient lymphocytes by recombinant interleukin 2: possible role for lymphokine-activated killer cell infusion in the in vivo-induced activation.
Gambacorti-Passerini C, Rivoltini L, Radrizzani M, Belli F, Sciorelli G, Ravagnani F, Galazka AR, Cascinelli N, Parmiani G. Gambacorti-Passerini C, et al. Among authors: galazka ar. Cancer Res. 1989 Sep 15;49(18):5230-4. Cancer Res. 1989. PMID: 2788498
44 results